期刊文献+

应对新冠肺炎期间武汉市接受抗病毒治疗艾滋病患者缺药风险评估 被引量:5

Antiretrovial Treatment Discontinuation Risk Assessment of HIV/AIDS Patients in Wuhan During the response of COVID-19
原文传递
导出
摘要 目的探索特殊情况下艾滋病患者抗病毒治疗药物保障措施。方法应对新型冠状病毒肺炎(简称新冠肺炎)期间采用电话调查的方法了解2020年1月1日至3月8日武汉市艾滋病患者抗病毒治疗药物领取情况,根据调查结果评估并解决其缺药风险。结果截至3月8日,武汉市正在接受抗病毒治疗艾滋病患者5517人,经评估5095人(92.35%)未来15天无缺药风险,228人(4.13%)缺药低风险,194人(3.52%)已缺药。疫情应对期间共4500人领药,其中2084人(46.31%)门诊自行取药,157人(3.49%)通过疾病预防控制中心或防艾志愿者上门送药获得药物,1735人(38.56%)通过邮寄方式获得药物,524人(11.64%)外地门诊借药。结论应对新冠肺炎期间,武汉市在治艾滋病患者存在缺药风险,但通过设立应急制度并提供多种取药途径,有效降低了缺药风险人群比例。 Objective To explore antiretroviral medicine safeguards for HIV/AIDS patients in extreme conditions.Methods We used a telephone survey to investigate the antiretroviral treatment situation of HIV/AIDS patients in Wuhan from January 1 st to March 8th,2020,assessed and solved the risk of ART discontinuation for these HIV/AIDS patients.Results A total of 5517 HIV/AIDS patients were receiving antiviral treatment in Wuhan until March 8th.We found that 92.35%of them with no risk of ART discontinuation,4.13%facing the risk of discontinuation in the next 15 days and 3.52%had discontinued.During the response of COVID-19,4500 people received antiretroviral medicines.2084(46.31%)of them went to the clinic for their medicines,157(3.49%)were delivered by local CDC or social volunteers,1735(38.56%)received the medicines by express delivery and 524(11.64%)borrowed medicine from other cities.Conclusion Although the supply of antiretroviral drugs against HIV have been disrupted during the pandemic of COVID-19 in Wuhan,the proportion of patients with ART discontinued has been effectively reduced by setting up an emergency system and providing a variety manners of drug access.
作者 胡雪姣 谢年华 闫晗 阮连国 罗燕和 刘恋 张倩 王兵 高明 王夏 HU Xuejiao;XIE Nianhua;YAN Han;RUAN Lianguo;LUO Yanhe;LIU Lian;ZHANG Qian;WANG Bing;GAO Ming;WANG Xia(Department for HIV/AIDS Prevention and Control,Wuhan Center for Disease Control and Prevention,Wuhan 430024,China;Jinyintan Hospital,Wuhan 430040;Caidian District Center for Disease Control and Prevention,Wuhan 430100;Qingshan District Center for Disease Control and Prevention,Wuhan 430080;Huangpi District Center for Disease Control and Prevention,Wuhan 430300;.Xinzhou District Center for Disease Control and Prevention,Wuhan 430400)
出处 《中国艾滋病性病》 CAS CSCD 北大核心 2021年第5期519-522,共4页 Chinese Journal of Aids & STD
基金 武汉市卫生和计划生育委员会医学科研项目面上重点项目(WG17A02)。
关键词 新型冠状病毒肺炎 艾滋病 抗病毒治疗 风险评估 COVID-19 HIV/AIDS Antiretroviral Treatment Risk Assessment
  • 相关文献

参考文献4

二级参考文献43

  • 1陈耕春.我国城市成年人心理健康监测指标优化—社会支持程度调查研究[J].西安体育学院学报,2001,18(1):99-101. 被引量:72
  • 2肖水源.《社会支持评定量表》的理论基础与研究应用[J].临床精神医学杂志,1994,4(2):98-100. 被引量:4004
  • 3严谨,肖水源.艾滋歧视研究进展[J].中国临床心理学杂志,2007,15(1):102-104. 被引量:49
  • 4孙丽君,王署照,姚勤伟,张可,黄春.农村地区艾滋病抗病毒治疗依从性及应对策略分析[J].中国艾滋病性病,2007,13(4):317-320. 被引量:31
  • 5张福杰,王健,王福生,等.国家免费艾滋病抗病毒药物治疗手册[M].3版.北京:人民卫生出版社,2012:183-185.
  • 6WHO.The strategic use of antiretrovirals to help end the HIV epidemic[M].Geneva:WHO,2012.
  • 7Ma Y,Zhao DC,Yu L,et al.Predictors of virologic failure in HIV-l-infected adults receiving first-line antiretroviral therapy in 8 provinces in China[J].Clin Infect Dis,2010,50 (2):264-271.DOI:10.1086/649215.
  • 8WHO. Global HIV/AIDS response: Epidemic update and health sector progress towards universal access: Progress report 2011 [ EB/OL]. [2013-02-15 ]. http://www.unaids. org/en/media/unaids/ contentassets/documents/unaidspublication/2011/20111130_UA_Report_en.pdf.
  • 9Jerene D, Naess A. Lindtjrn B. Antiretroviral therapy at a district hospital in Ethiopia Drevellts death and tuberculosis in a cohort of HIV patients[J]. AIDS Res Ther, 2006,3:10. DOI: 10.1186/1742-6405-3-10.
  • 10Li JZ, Paredes R, Ribaudo H J, et al. Relationship between minoriy nonnueleoside reverse transeriptase inhibitor resistanee mutations, adherenee, and the risk of virologic failure[J]. AIDS, 2012,26(2): 185-192.DO1:10.1097/QAI).0b013e32834e9d7d.

共引文献196

同被引文献53

引证文献5

二级引证文献23

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部